Ricevi le ultime notizie sulle azioni Aptorum Group con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di APM

Ultime notizie per

Aptorum Gr

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Group

Panoramica

Notizie

Utili

Vendite allo scoperto

Rapporto azionario

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Comments

Aptorum Group Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO